麻豆传媒

Gastroenterology >

Hepatitis

News, opinions and meeting coverage in gastroenterology.

Did OxyContin Reformulation Boost HCV Rates?

Association suggests "unintended consequence" of abuse deterrent opioids

HCV Combo Pill a Winner in Untreated Cirrhotic Patients

High SVR12 rate suggests 8-week treatment could be used for this population

Hepatitis C Treatment Works Well for Young Kids

Nearly all children treated with sofosbuvir/ledipasvir achieved sustained response

Pregnant Women at Risk for HCV Benefit from Universal Screen

Test deemed more efficient, cost-effective diagnostic approach versus risk-based screening

Liver Meeting to Focus on Practice Matters Along with Science

Topics range from 'day in the life' of a hepatology consultant to novel NASH therapies

ACIP: Routinely Vaccinate Homeless Against HepA

Homelessness denotes increased risk for contracting disease

Outbreak-Related Hep A Infections on the Rise

2017 data showed dramatic increases

FDA Approves New Formulation of HepA Immune Globulin

Product also offers post-exposure prophylaxis against measles

Proposed: Screen Patients with Certain Infections for Opioid Addiction

Expert panel identifies endocarditis, skin abscess, others as flags for drug abuse

Shorter Wait Times May Favor HCV-Infected Kidney Transplants

Long-term dialysis while waiting for uninfected kidney a larger risk

Medicaid or No Insurance Tied to Higher Death Risk in HCV

All public plans lead to higher mortality rates, according to 10-year study

Hepatitis D: The 'Forgotten Virus' is Still Here

More attention to screening, treatment is needed, say experts

Survival Prognosis Still Poor for Alcoholic Hepatitis

Four decades of no improvement show urgent need for better treatments

It's Official! Curing Patients Is Bad for Business

Milton Packer describes the end result of profit-dominated drug development

Hepatitis C Treatments Reduce Transplants

Therapies also appear to reduce liver-related mortality

Europe Gets Updated HCV Tx Guidelines

EASL panel touts 'ease of use' of direct-acting antivirals

ACIP Backs Hep A Vax in Outbreaks

Unanimous vote to support use as post-exposure prophylaxis

ACIP Reinstates FluMist for 2018-2019 Flu Season

Committee persuaded by new efficacy analyses

Experts Raise Red Flag over Fatty Liver Disease

Paints gloomy picture for population health, economy

Vets with HCV Might Settle Cancer Controversy

VA experience seems to rule out possible cancer-causing effect of new drugs

Novel Tx for Hepatic Encephalopathy Works Fast

Lowers ammonia level more quickly than standard care, study finds

Liver Ca Transplant Rates Vary by Ethnicity

Blacks have lower rates despite same degree of illness, study finds

AASLD Liver Meeting Covers a Lot of Ground

New science could 'potentially change the field'

Hepatitis A Outbreak to Greet IDWeek

Homeless bear brunt of disease; delegates at low risk

Morning Break: Antibiotics Running Out; Teen Sex Interest Drops; Children Drive to OR

Health news and commentary from around the Web gathered by the 麻豆传媒 staff

Does a New Hepatitis Vaccine Cause Heart Attacks?

In this Revolution and Revelation, Milton Packer asks how you would answer this question

AIDS Science Meeting Returns to Paris

Leaders vow to battle to preserve research into virus

Gilead's 3-Drug Combo Pill OK'd for 2nd-Line HCV Treatment

Indicated for all six HCV genotypes in patients needing retreatment

DDW 2017: Diversity Will Be Meeting's Strength

Four-society meeting has plenty to offer across and among specialties

ACIP: One-Dose HepB Vax OK for Some Infants Needing Revaccination

Two more doses needed if infant still non-responsive after testing, committee advises

Coffee, Genetics May Block Hepatitis in Heavy Drinkers

Gene variant also shows possible liver-protective effect

Hep C Virus Outbreak Tied to Unsafe Injection Practices

Calif. prolotherapy clinic shuttered after patients developed HCV infections

Investigative Combo Pill Effective Against HCV Infection

Treating refractory HCV without ribavirin onboard.

Simple, Short HCV Regimen Has High Cure Rate

LONDON -- A single pill once a day for 8 weeks is enough to cure more than 90% of hepatitis C virus patients with relatively uncomplicated disease, a researcher said.

Treating HCV -- Is the Price Right?

New drugs on the horizon hold out the promise of being able to cure up to 90% of people with chronic hepatitis C (HCV). They are also promising to be expensive.

Studies 'Validate' CDC HCV Testing Advice

WASINGTON -- Thousands of people in the U.S. -- including an estimated 50,000 veterans -- are infected with the hepatitis C virus, and don't know it, researchers reported here.

Babies Do OK if Mom on Tenofovir for Hepatitis B

WASHINGTON -- Pregnant women being treated for hepatitis B virus infections with the nucleotide inhibitor tenofovir (Viread) appeared to avoid transmission of the pathogen to their unborn children, researchers reported here.

Interferon-Free Hepatitis C Tx Hits Snag

SEATTLE -- Results in a hard-to-treat patient population have clouded the future of a closely watched agent that acts against hepatitis C directly.

FDA Adds More Warnings for Lipitor, Crestor, and Zocor

WASHINGTON -- Statins may cause drug-drug interactions for patients taking drugs to treat HIV/AIDS or hepatitis C, according to a new statin warning from the FDA.

Herbal Supplement Suspect in Hepatitis

An herbal supplement containing artemisinin may have triggered hepatitis in a Seattle man who was given the supplement by a naturopathic provider for treatment of a parasitic infection.

3